Xiang Zou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Xiang Zou has a total of 85 co-authors. Here are the top co-authors by number of shared publications:
Xingran Xu
College of Pharmaceutical Sciences, Southwest University, Chongqing 400715, China
9 shared publicationsFulin Li
College of Pharmaceutical Sciences, Southwest University, Chongqing 400715, China; National Citrus Engineering Research Center, Southwest University, Chongqing 400712, China
6 shared publicationsJun Feng
College of Pharmaceutical Sciences, Southwest University, Chongqing 400715, PR China
5 shared publicationsGuangwei Tu
4 shared publicationsJing Yang
College of Pharmaceutical Sciences, Southwest University, 2 Tian Sheng Road, Beibei, Chongqing 400715, P. R. China
4 shared publicationsPan Wang
College of Pharmaceutical Sciences, Southwest University, 2 Tian Sheng Road, Beibei, Chongqing 400715, P. R. China
4 shared publications
Latest Publications
- 17 July 2026
- Published by Elsevier in Bioresource Technology
- Vol. 460, 135438
De novo biosynthesis of synephrine in engineered Escherichia coli
- 17 July 2026
- Published by Elsevier in Bioresource Technology
- Vol. 460, 135438
De novo biosynthesis of synephrine in engineered Escherichia coli
- Open Access
- 30 April 2026
- Published by Elsevier in SSRN Electronic Journal
De novo biosynthesis of synephrine in engineered Escherichia coli
Synephrine, the most abundant and active alkaloid in Citrus aurantium, is utilized in the treatment of bronchial asthma, hypotension, collapse, shock, and orthostatic hypotension. However, the extraction of synephrine from plant sources is hindered by several limitations, including low natural abundance, inefficient extraction, and complex purification steps. In this study, we developed a de novo biosynthetic platform for synephrine production. We first validated the catalytic activity of three key enzymes-TYDC, MwDβH, and hPNMT- in the synephrine synthesis pathway through in vitro biocatalytic assays. These enzymes were then expressed in a tyrosine-producing strain of Escherichia coli BAK11, enabling de novo biosynthesis of synephrine from glucose. To enhance production, we screened and engineered the β-hydroxylase, an engineered strain with a truncated variant of the β-hydroxylase achieved 2.7-fold improve synephrine production compared to the initial strain. Using fed-batch fermentation with glucose as the sole carbon source, a titer of 88.1 mg/L synephrine was achieved in a 5-L fermenter. To our knowledge, this represents the first report of de novo microbial synthesis of synephrine. Our work provides a novel, cost-effective, and sustainable strategy for the biobased production of synephrine.
- 30 April 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessDe novo biosynthesis of synephrine in engineered Escherichia coli
Synephrine, the most abundant and active alkaloid in Citrus aurantium, is utilized in the treatment of bronchial asthma, hypotension, collapse, shock, and orthostatic hypotension. However, the extraction of synephrine from plant sources is hindered by several limitations, including low natural abundance, inefficient extraction, and complex purification steps. In this study, we developed a de novo biosynthetic platform for synephrine production. We first validated the catalytic activity of three key enzymes-TYDC, MwDβH, and hPNMT- in the synephrine synthesis pathway through in vitro biocatalytic assays. These enzymes were then expressed in a tyrosine-producing strain of Escherichia coli BAK11, enabling de novo biosynthesis of synephrine from glucose. To enhance production, we screened and engineered the β-hydroxylase, an engineered strain with a truncated variant of the β-hydroxylase achieved 2.7-fold improve synephrine production compared to the initial strain. Using fed-batch fermentation with glucose as the sole carbon source, a titer of 88.1 mg/L synephrine was achieved in a 5-L fermenter. To our knowledge, this represents the first report of de novo microbial synthesis of synephrine. Our work provides a novel, cost-effective, and sustainable strategy for the biobased production of synephrine.
- Open Access
- 23 March 2026
- Published by Elsevier in SSRN Electronic Journal
Identification of a thermotolerant strain of Aureobasidium melanogenum DA22 and functional analysis of Spt23 as a key transcriptional regulator in high-temperature polymalic acid fermentation
The industrial application of Aureobasidium pullulans in organic acid production is substantially limited by its mesophilic characteristics, which impair cellular growth and reduce metabolic activity under thermal stress. Enhancing intrinsic thermotolerance is therefore crucial to achieving energy-efficient, high-temperature fermentation processes. In this study, physiological screening of 120 wild-type isolates led to the identification of a naturally robust strain, A. melanogenum DA22, which maintained near-optimal growth with a biomass of 20.77 g/L and preserved 93.8% of its maximum polymalic acid (PMA) titer, reaching 24.55 g/L (calculated as L-malic acid, L-MA) at 35°C. To confer thermotolerance to a high-PMA-yield A. pullulans chassis, candidate thermoprotective genes―including heat shock proteins, antioxidant enzymes, and transcription factor―were identified from strain DA22. Among them, overexpression of the membrane-associated transcription factor gene SPT23 resulted in a 20.0% increase in cell growth and a 37.7% enhancement in L-MA production, from 28.96 g/L to 39.86 g/L at 35°C. In contrast, deletion of SPT23 caused severe morphological defects and widespread metabolic repression. RT-qPCR analysis also indicated that SPT23 overexpression coordinately upregulated genes involved in lipid and ergosterol biosynthesis, thereby maintaining membrane integrity under thermal stress. Furthermore, the engineered strain showed significantly elevated expression of key enzymes in the reductive tricarboxylic cycle (rTCA) and the PMA biosynthesis pathways. Together, these results demonstrate a dual regulatory mechanism in which Spt23 concurrently stabilizes membrane structure and redirects metabolic flux toward PMA biosynthesis, providing a thermotolerant microbial cell factory suitable for organic acid production under industrial thermal-stress conditions.
- 23 March 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessIdentification of a thermotolerant strain of Aureobasidium melanogenum DA22 and functional analysis of Spt23 as a key transcriptional regulator in high-temperature polymalic acid fermentation
The industrial application of Aureobasidium pullulans in organic acid production is substantially limited by its mesophilic characteristics, which impair cellular growth and reduce metabolic activity under thermal stress. Enhancing intrinsic thermotolerance is therefore crucial to achieving energy-efficient, high-temperature fermentation processes. In this study, physiological screening of 120 wild-type isolates led to the identification of a naturally robust strain, A. melanogenum DA22, which maintained near-optimal growth with a biomass of 20.77 g/L and preserved 93.8% of its maximum polymalic acid (PMA) titer, reaching 24.55 g/L (calculated as L-malic acid, L-MA) at 35°C. To confer thermotolerance to a high-PMA-yield A. pullulans chassis, candidate thermoprotective genes―including heat shock proteins, antioxidant enzymes, and transcription factor―were identified from strain DA22. Among them, overexpression of the membrane-associated transcription factor gene SPT23 resulted in a 20.0% increase in cell growth and a 37.7% enhancement in L-MA production, from 28.96 g/L to 39.86 g/L at 35°C. In contrast, deletion of SPT23 caused severe morphological defects and widespread metabolic repression. RT-qPCR analysis also indicated that SPT23 overexpression coordinately upregulated genes involved in lipid and ergosterol biosynthesis, thereby maintaining membrane integrity under thermal stress. Furthermore, the engineered strain showed significantly elevated expression of key enzymes in the reductive tricarboxylic cycle (rTCA) and the PMA biosynthesis pathways. Together, these results demonstrate a dual regulatory mechanism in which Spt23 concurrently stabilizes membrane structure and redirects metabolic flux toward PMA biosynthesis, providing a thermotolerant microbial cell factory suitable for organic acid production under industrial thermal-stress conditions.
- 9 October 2024
- Published by Elsevier in Bioresource Technology
- Vol. 414, 131578
Engineering the by-products pathway in Aureobasidium pullulans for highly purified polymalic acid fermentation with concurrent recovery of l-malic acid
- 9 October 2024
- Published by Elsevier in Bioresource Technology
- Vol. 414, 131578
Engineering the by-products pathway in Aureobasidium pullulans for highly purified polymalic acid fermentation with concurrent recovery of l-malic acid
- 20 February 2024
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
- Vol. 72 (9) , 4538-4551
Recent Advances in Microbial Metabolic Engineering for Production of Natural Phenolic Acids
Phenolic acids are important natural bioactive compounds with varied physiological functions. They are extensively used in food, pharmaceutical, cosmetic, and other chemical industries and have attractive market prospects. Compared to plant extraction and chemical synthesis, microbial fermentation for phenolic acid production from renewable carbon sources has significant advantages. This review focuses on the structural information, physiological functions, current applications, and biosynthesis pathways of phenolic acids, especially advances in the development of metabolically engineered microbes for the production of phenolic acids. This review provides useful insights concerning phenolic acid production through metabolic engineering of microbial cell factories.
- 20 February 2024
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
- Vol. 72 (9) , 4538-4551
Recent Advances in Microbial Metabolic Engineering for Production of Natural Phenolic Acids
Phenolic acids are important natural bioactive compounds with varied physiological functions. They are extensively used in food, pharmaceutical, cosmetic, and other chemical industries and have attractive market prospects. Compared to plant extraction and chemical synthesis, microbial fermentation for phenolic acid production from renewable carbon sources has significant advantages. This review focuses on the structural information, physiological functions, current applications, and biosynthesis pathways of phenolic acids, especially advances in the development of metabolically engineered microbes for the production of phenolic acids. This review provides useful insights concerning phenolic acid production through metabolic engineering of microbial cell factories.
- 13 October 2022
- Published by Elsevier in Journal of Biotechnology
- Vol. 359, 176-184
MAL31, a sugar transporter involved in pullulan biosynthesis in Aureobasidium pullulans
- 13 October 2022
- Published by Elsevier in Journal of Biotechnology
- Vol. 359, 176-184
MAL31, a sugar transporter involved in pullulan biosynthesis in Aureobasidium pullulans